由于R213G多态的SOD3表达的重新分配会影响肺间歇性巨细胞的重编程,以应对缺氧
Caitlin V Lewis1,2, Anastacia M Garcia3, Samuel D Burciaga1,2
1Cardiovascular Pulmonary Research Laboratories, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
Physiological genomics
|September 23, 2024
概括
超氧化物脱酶3 (SOD3) 中的R213G单核酸多态 (SNP) 在缺氧期间不会增加肺巨细胞,但会改变它们的代谢和炎症反应,恶化肺高血压 (PH). 这种SOD3变体损害了巨细胞对低氧压力的代谢适应,阻碍了炎症的解决.
科学领域:
- 肺高血压的发病因子 肺高血压的发病因子
- 巨细胞生物学和新陈代谢
- 细胞外矩阵重塑 细胞外矩阵重塑
背景情况:
- 细胞外超氧化物失突酶 (SOD3) 水平在肺高血压 (PH) 中降低.
- SOD3 R213G单核酸多态 (SNP) 将SOD3从细胞外基质 (ECM) 迁移到细胞外液体中,增加心血管疾病风险并恶化缺氧PH.
- 间歇性巨细胞 (IMs) 在PH发育中起着至关重要的作用.
研究的目的:
- 为了调查R213G SOD3 SNP是否影响间歇性巨细胞 (IM) 积累,以应对低氧.
- 确定R213G SOD3 SNP在低氧条件下如何影响IM重编程.
- 阐明R213G SNP对长期缺氧期间巨细胞代谢和炎症反应的影响.
主要方法:
- 使用R213G突变和野生型 (WT) 鼠标暴露于低性缺氧.
- 采用流细胞计量来量化IM群体在不同的时间点 (4和14天).
- 进行RNA测序和Agilent海马对隔离的IM进行测定,以分析基因表达和代谢功能 (糖解).
主要成果:
- 在R213G和WT小鼠中,缺氧暂时增加了IMs;R213G SNP没有加剧IM积累.
- RNA测序显示,来自R213G小鼠的低氧暴露的IMs表现出与ECM相关和促炎途径的激活.
- 与WT IMs相比,R213G IMs显示出淡的抗炎反应,缺乏代谢重塑,特别是受损的葡萄糖分解上调.
结论:
- R213G SOD3 SNP通过改变巨细胞的表型而不是增加它们的数量来加剧慢性缺氧PH.
- R213G巨细胞表现出对低氧的代谢适应受损,导致持续的炎症信号传递和炎症分辨率降低.
- 这些发现强调了巨细胞在PH中的代谢重编程的关键作用,并表明了与氧化还原调节和ECM通路相关的潜在治疗点.
相关概念视频
Exon Recombination
3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon...
Exon shuffling follows “splice frame rules.” Each exon...
3.6K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


